直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Securing $240 million and a jury verdict of willful infringement for Promptu in patent case against Comcast

Promptu Systems Corporation

US Synthetic secures ITC exclusion order barring polycrystalline diamond compacts (PDCs)

US Synthetic Corporation

Achieving precedent in preserving valuable patents for Lumify®

Eye Therapies, LLC

Finnegan client Maglula delivers crushing blow to Amazon’s arbitration practices over counterfeit products

Maglula, Ltd.

Finnegan secures $180M for CSRC in complex arbitrations

CSRC et al.

Protecting a blockbuster diabetes treatment for AstraZeneca

AstraZeneca AB

Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini

Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.

Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement

Eisai Co., Ltd.

Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million

Intellia Therapeutics, Inc.

Recent Experience

Experience

Rocket Pharmaceuticals, Inc. v. Beard et al.

Rocket Pharmaceuticals, Inc. v. Beard et al.

3:24-cv-02170, D. Or., Judge Simon

Experience

Rocket Pharmaceuticals, Inc. v. Lexeo Therapeutics, Inc., et al.

Rocket Pharmaceuticals, Inc. v. Lexeo Therapeutics, Inc., et al.

1:23-cv-09000, S.D.N.Y., Judges Castel, Aaron

Experience

Bay Materials, LLC v. 3M Company Bay Materials, LLC v. 3M Company

1:21-cv-01610, D. Del., Judges Andrews, Hall

Experience

AbbVie Inc. et al v. Alvotech hf. AbbVie Inc. et al v. Alvotech hf.

1:21-cv-02258, 1:21-cv-02899, N.D. Ill., Judge Lee

Experience

Teva Pharmaceuticals International GmbH v. Eli Lilly and Company Teva Pharmaceuticals International GmbH v. Eli Lilly and Company

2020-1747, -1748, -1749, -1750, -1751, -1752, -1876, -1877, -1878, Fed. Cir.

Experience

Bial - Portela & CA S.A. v. Alkem Laboratories Ltd et al. Bial - Portela & CA S.A. v. Alkem Laboratories Ltd et al.

1:18-cv-00304, D. Del., Judges Connolly, Burke

Experience

Computer Sciences Corporation v. Tata Consultancy Services Limited et al. Computer Sciences Corporation v. Tata Consultancy Services Limited et al.

3:19-cv-00970, N.D. Tex., Judges Ramirez, Starr

Experience

Daicel Corporation v. Celanese International Corp. Daicel Corporation v. Celanese International Corp.

18-2130, -2131, Fed. Cir.

Experience

Pozen Inc. v. Dr. Reddy’s Laboratories Inc. Pozen Inc. v. Dr. Reddy’s Laboratories Inc.

17-2473, Fed. Cir.

Experience

Federal Circuit reverses IPR decision, invalidates all claims challenged by Finnegan clients DuPont and Archer-Daniels-Midland - E. I. du Pont de Nemours and Co. v. Synvina C.V., 17-1977, Fed. Cir.

Federal Circuit reverses IPR decision, invalidates all claims challenged by Finnegan clients DuPont and Archer-Daniels-Midland Federal Circuit reverses IPR decision, invalidates all claims challenged by Finnegan clients DuPont and Archer-Daniels-Midland

17-1977, Fed. Cir.

Experience

Ferring B.V. v. Allergan, Inc. Ferring B.V. v. Allergan, Inc.

1:12-cv-02650, S.D.N.Y., Judges Cott, Sweet

Experience

Sandoz Inc. v. AbbVie Biotechnology, Ltd Sandoz Inc. v. AbbVie Biotechnology, Ltd

IPR2018-00002, -00156, IPR2017 -01824, -02106, -02105, PTAB, Judges Ankenbrand, Hulse, Mitchell

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP